148 related articles for article (PubMed ID: 24922641)
1. Heparanase and COX-2 expression as predictors of lymph node metastasis in large, high-grade breast tumors.
Gawthorpe S; Brown JE; Arif M; Nightingale P; Nevill A; Carmichael AR
Anticancer Res; 2014 Jun; 34(6):2797-800. PubMed ID: 24922641
[TBL] [Abstract][Full Text] [Related]
2. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
5. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
[TBL] [Abstract][Full Text] [Related]
6. The importance of COX-2 expression as prognostic factor in early breast cancer.
Kargi A; Uysal M; Bozcuk H; Coskun HS; Savas B; Ozdogan M
J BUON; 2013; 18(3):579-84. PubMed ID: 24065467
[TBL] [Abstract][Full Text] [Related]
7. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
[TBL] [Abstract][Full Text] [Related]
8. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between lymph-node metastasis and combined expression of Hpa and C-erbB-2 of invasive ductal breast carcinoma].
Zheng XD; Xiao CB; Mao DH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):52-4. PubMed ID: 18390199
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways.
Schmitz KJ; Callies R; Wohlschlaeger J; Kimmig R; Otterbach F; Bohr J; Lee HS; Takeda A; Schmid KW; Baba HA
J Clin Pathol; 2006 Jul; 59(7):685-91. PubMed ID: 16497869
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of expression of heparanase to angiogenesis and prognosis of breast cancer].
Liu ZZ; Zhang HW; Wei B; Cui SD
Ai Zheng; 2004 Nov; 23(11):1342-5. PubMed ID: 15522187
[TBL] [Abstract][Full Text] [Related]
13. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
[TBL] [Abstract][Full Text] [Related]
15. Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program.
González-Sistal A; Sánchez AB; Del Rio MC; Arias JI; Herranz M; Ruibal A
Anticancer Res; 2014 Jan; 34(1):269-73. PubMed ID: 24403473
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of cyclooxygenase 2 and Bcl-2 for cervical lymph node metastasis in mucoepidermoid carcinoma.
Zyada MM; Grawish ME; Elsabaa HM
Ann Diagn Pathol; 2009 Oct; 13(5):313-21. PubMed ID: 19751908
[TBL] [Abstract][Full Text] [Related]
17. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both?
Raica M; Cîmpean AM; Ceausu RA; Fulga V; Nica C; Rudico L; Saptefrati L
Anticancer Res; 2014 Mar; 34(3):1435-40. PubMed ID: 24596391
[TBL] [Abstract][Full Text] [Related]
19. The close relationship between heparanase and cyclooxygenase-2 expressions in signet-ring cell carcinoma of the stomach.
Ohtawa Y; Naomoto Y; Shirakawa Y; Takaoka M; Murata T; Sonoda R; Sakurama K; Yamatsuji T; Gunduz M; Tsujigiwa H; Nagatsuka H; Terada N; Itano S; Horiki S; Yanagihara K; Nakajima M; Tanaka N
Hum Pathol; 2006 Sep; 37(9):1145-52. PubMed ID: 16938519
[TBL] [Abstract][Full Text] [Related]
20. Can cyclo-oxygenase-2 be a useful prognostic and risk stratification marker in breast cancer?
Jana D; Sarkar DK; Maji A; Chikkala BR; Hassanujjaman S; Mukhopadhyay M; Ganguly S
J Indian Med Assoc; 2012 Jul; 110(7):429-33. PubMed ID: 23520664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
